The total size of the restorative dentistry market was USD 15,789.2 million in 2022, and it will grow at a rate of 6.2% in the years to come, to reach USD 25,608.0 million by 2030, according to P&S Intelligence, a market research firm.
 |
| To learn more about this report: https://bit.ly/41T1a45 |
There is a considerable increase in the incidence of oral health problems globally, particularly among youngsters and the aging people recently. Caries is the most common of these conditions, missing teeth, and periodontal diseases contributing to the increasing acceptance of restorative dentistry.
Dental prosthetics will grow at a rate of about 8% in the years to come. This has a lot to do with the growing demand for dental procedures as a result of the increasing frequency of tooth decay, teeth loss, and other oral health conditions.
The implantology category dominated the restorative dentistry market, with about 50% share, in 2022, and it will grow the fastest in the years to come, due to the growing requirement for dental implants in developed nations.
Europe had the largest share of revenue of, about 45%. This is because of the increasing frequency of dental diseases, the rising geriatric population, the incidence of leading players, and the booming expenditure of the governments on dental care.
Metallic and ceramic dental implants generate most of the revenue in Europe. Zirconia-based ceramic implants are extensively favored by patients with issues of tooth sensitivity.
Moreover, the U.K. is growing because of the early acceptance of dental implant procedures, growing healthcare spending, and rising awareness on dental hygiene. The growing geriatric population is also powering the market in the nation.
Moreover, APAC will grow the fastest because of huge patient base in India and China. Furthermore, government initiatives and the medical industry expansion are will power the market development in the near future.
Due to the growing requirement of cosmetic and dental surgeries, the demand for restorative dentistry treatments will continue to grow considerably by the end of this decade.
